Bradley L Campbell - Net Worth and Insider Trading
Bradley L Campbell Net Worth
The estimated net worth of Bradley L Campbell is at least $9 Million dollars as of 2024-04-26. Bradley L Campbell is the President and CEO of Amicus Therapeutics Inc and owns about 886,654 shares of Amicus Therapeutics Inc (FOLD) stock worth over $9 Million. Details can be seen in Bradley L Campbell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bradley L Campbell has not made any transactions after 2024-04-01 and currently still holds the listed stock(s).
Transaction Summary of Bradley L Campbell
Bradley L Campbell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bradley L Campbell owns 4 companies in total, including Amicus Therapeutics Inc (FOLD) , ARYA Sciences Acquisition Corp III (ARYA) , and Progenics Pharmaceuticals Inc (PGNX) among others .
Click here to see the complete history of Bradley L Campbell’s form 4 insider trades.
Insider Ownership Summary of Bradley L Campbell
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FOLD | Amicus Therapeutics Inc | 2024-04-01 | director & President and CEO |
ARYA | ARYA Sciences Acquisition Corp III | 2020-08-06 | director |
PGNX | Progenics Pharmaceuticals Inc | 2020-06-19 | director |
NAUT | Nautilus Biotechnology Inc | 2020-08-06 | director |
Bradley L Campbell Latest Holdings Summary
Bradley L Campbell currently owns a total of 1 stock. Bradley L Campbell owns 886,654 shares of Amicus Therapeutics Inc (FOLD) as of April 1, 2024, with a value of $9 Million.
Latest Holdings of Bradley L Campbell
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
FOLD | Amicus Therapeutics Inc | 2024-04-01 | 886,654 | 10.17 | 9,017,271 |
Holding Weightings of Bradley L Campbell
Bradley L Campbell Form 4 Trading Tracker
According to the SEC Form 4 filings, Bradley L Campbell has made a total of 58 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years, including 0 buys and 58 sells. The most-recent trade in Amicus Therapeutics Inc is the sale of 7,500 shares on April 1, 2024, which brought Bradley L Campbell around $87,525.
Insider Trading History of Bradley L Campbell
- 1
Bradley L Campbell Trading Performance
Bradley L Campbell Ownership Network
Ownership Network List of Bradley L Campbell
Ownership Network Relation of Bradley L Campbell
Bradley L Campbell Owned Company Details
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
Bradley L Campbell is the director & President and CEO of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & Executive Chairman John F Crowley , Chief People Officer David Michael Clark , and General Counsel & Corp. Secy Ellen Rosenberg .
Amicus Therapeutics Inc (FOLD) Insider Trades Summary
Over the past 18 months, Bradley L Campbell made 21 insider transaction in Amicus Therapeutics Inc (FOLD) with a net sale of 258,416. Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 645,546 shares made by John F Crowley , a net sale of 51,919 shares made by David Michael Clark , and a net sale of 126,839 shares made by Ellen Rosenberg .
In summary, during the past 3 months, insiders sold 185,169 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 185,169 shares. During the past 18 months, 1,242,298 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,242,298 shares.
Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
Bradley L Campbell Mailing Address
Above is the net worth, insider trading, and ownership report for Bradley L Campbell. You might contact Bradley L Campbell via mailing address: C/o Amicus Therapeutics, Inc., 1 Cedar Brook Drive, Cranbury Nj 08512.